We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
-0.5%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$75.5M
AUM Growth
+$8.01M
Cap. Flow
+$8.15M
Cap. Flow %
10.79%
Top 10 Hldgs %
33.84%
Holding
120
New
37
Increased
26
Reduced
20
Closed
30

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$1.8M
2
CI icon
Cigna
CI
+$1.51M
3
ABBV icon
AbbVie
ABBV
+$1.05M
4
RRC icon
Range Resources
RRC
+$1.01M
5
UNH icon
UnitedHealth
UNH
+$973K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.74M
2
VYGR icon
Voyager Therapeutics
VYGR
+$1.64M
3
BAX icon
Baxter International
BAX
+$1.6M
4
META icon
Meta Platforms (Facebook)
META
+$1.25M
5
NOW icon
ServiceNow
NOW
+$1.19M

Sector Composition

Rank Sector Weight
1 Healthcare 42.39%
2 Energy 5.97%
3 Technology 5.96%
4 Industrials 3.87%
5 Communication Services 3.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KMX icon
51
CarMax
KMX
$8.24B
$448K 0.59%
+6,956
New +$390K
HON icon
52
Honeywell
HON
$76.3B
$440K 0.58%
+4,200
New +$427K
SCHW
53
Charles Schwab
SCHW
$187B
$436K 0.58%
+11,056
New +$395K
VYGR icon
54
Voyager Therapeutics
VYGR
$189M
$436K 0.58%
34,256
-128,022
-79% -$1.64M
AMAT icon
55
Applied Materials
AMAT
$419B
$421K 0.56%
+13,054
New +$397K
MYOK
56
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$421K 0.56%
32,496
+6,998
+27% +$108K
ZLTQ
57
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$411K 0.54%
9,438
-1,207
-11% -$48.7K
XBI icon
58
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$379K 0.5%
+6,400
New +$395K
COLL icon
59
Collegium Pharmaceutical
COLL
$944M
$370K 0.49%
23,769
+16,616
+232% +$276K
OVV icon
60
Ovintiv
OVV
$16.6B
$369K 0.49%
+6,287
New +$358K
MTD icon
61
Mettler-Toledo International
MTD
$28.5B
$353K 0.47%
+843
New +$351K
PEN icon
62
Penumbra
PEN
$12.8B
$340K 0.45%
5,333
+871
+20% +$58.2K
PTLA
63
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$325K 0.43%
+14,472
New +$283K
CME icon
64
CME Group
CME
$95B
$316K 0.42%
2,736
-6,306
-70% -$702K
TEX icon
65
Terex
TEX
$7.47B
$307K 0.41%
+9,743
New +$270K
BPMC
66
DELISTED
Blueprint Medicines
BPMC
$298K 0.39%
10,635
+1,373
+15% +$41.4K
MOH icon
67
Molina Healthcare
MOH
$10B
$279K 0.37%
5,140
-4,126
-45% -$226K
NXGN
68
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$241K 0.32%
+18,291
New +$234K
CSII
69
DELISTED
Cardiovascular Systems, Inc.
CSII
$236K 0.31%
9,729
-578
-6% -$14.2K
ARAY icon
70
Accuray
ARAY
$33.8M
$219K 0.29%
47,709
-13,751
-22% -$71.3K
BAC icon
71
Bank of America
BAC
$441B
$218K 0.29%
+9,875
New +$190K
ARCH
72
DELISTED
Arch Resources, Inc.
ARCH
$217K 0.29%
+2,781
New +$210K
GDDY icon
73
GoDaddy
GDDY
$11.4B
$212K 0.28%
+6,062
New +$213K
RGNX icon
74
Regenxbio
RGNX
$745M
$212K 0.28%
11,449
+5,323
+87% +$102K
VMC icon
75
Vulcan Materials
VMC
$36.5B
$211K 0.28%
1,687
– –
1 2
3
4 5

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q4 2016 Portfolio in Review

As of Q4 2016, Partner Investment Management held 120 positions worth $75.5M, up 12% from $67.5M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Partner Investment Management deployed $8.15M of net new capital in Q4 2016, opening 37 new positions and adding to 26 existing holdings. Its largest new stake was Elevance Health: 13,462 shares worth $1.94M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 42% a quarter earlier, followed by Energy and Technology.

On the sell side, the largest reduction was Voyager Therapeutics, an estimated $1.64M trimmed.

  • Partner Investment Management's largest Q4 2016 buy was Elevance Health: 13,462 shares worth $1.94M.
  • Partner Investment Management added most to Cigna in Q4 2016, an estimated $1.51M increase.
  • Partner Investment Management's biggest Q4 2016 reduction was Voyager Therapeutics, cutting an estimated $1.64M.
  • Partner Investment Management fully exited Apple in Q4 2016, selling an estimated $1.74M.
  • Partner Investment Management's ten largest holdings make up 34% of its $75.5M portfolio in Q4 2016.
  • Partner Investment Management opened 37 new positions and closed 30 in Q4 2016.
  • Partner Investment Management's portfolio value rose 12% quarter-over-quarter to $75.5M.

Based on Partner Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.